“Phase 2 Study of Cemiplimab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s124. https://doi.org/10.25251/skin.4.supp.124.